Search

The G4C2-repeat expansion in C9orf72 is the most common cause of frontotemporal dementia and of amyotrophic lateral sclerosis. The variability of age at onset and phenotypic presentations is a hallmark of C9orf72 disease. In this study, we aimed to identify modifying factors of disease onset in C9orf72 carriers using a family-based approach, in pairs of C9orf72 carrier relatives with concordant or discordant age at onset. Linkage and association analyses provided converging evidence for a locus on chromosome Xq27.3. The minor allele A of rs1009776 was associated with an earlier onset (P = 1 × 10−5). The association with onset of dementia was replicated in an independent cohort of unrelated C9orf72 patients (P = 0.009). The protective major allele delayed the onset of dementia from 5 to 13 years on average depending on the cohort considered. The same trend was observed in an independent cohort of C9orf72 patients with extreme deviation of the age at onset (P = 0.055). No association of rs1009776 was detected in GRN patients, suggesting that the effect of rs1009776 was restricted to the onset of dementia due to C9orf72. The minor allele A is associated with a higher SLITRK2 expression based on both expression quantitative trait loci (eQTL) databases and in-house expression studies performed on C9orf72 brain tissues. SLITRK2 encodes for a post-synaptic adhesion protein. We further show that synaptic vesicle glycoprotein 2 and synaptophysin, two synaptic vesicle proteins, were decreased in frontal cortex of C9orf72 patients carrying the minor allele. Upregulation of SLITRK2 might be associated with synaptic dysfunctions and drives adverse effects in C9orf72 patients that could be modulated in those carrying the protective allele. How the modulation of SLITRK2 expression affects synaptic functions and influences the disease onset of dementia in C9orf72 carriers will require further investigations. In summary, this study describes an original approach to detect modifier genes in rare diseases and reinforces rising links between C9orf72 and synaptic dysfunctions that might directly influence the occurrence of first symptoms.

International audience; A mixture of copper complex and Al/CuO nanothermite, Al/CuO/CuC, represents one of the state-of-the-art gas-generating thermite systems with various pyrotechnic applications due to its tunable gas release rates. The reactivity of reactive inks with various loadings of the poly(vinylpyrrolidone) (PVP) binder mixed with Al/CuO/CuC is characterized using high-speed imaging diagnostics and pressure measurements. For a PVP mass fraction of

The main objective of this work was to find the most efficient method to interpolate metal oxide gas sensor used in a pulsed-temperature operating mode. This pulsed thermal profile is obtained by applying 6 power steps of 2 s each on the heater resistor. The experimental values of the sensing layer resistance, with a sampling time of 4 ms, were interpolated by using two different static methods: a polynomial modelling and a neural network modelling, and one dynamic method: the diffusive representation. Then, the results have been compared in terms of precision and number of useful output data, as minimum as possible for high performance and rapid data treatment which is great of interest in embedded systems. The best results are obtained with the diffusive representation, it allows converting 500 measurements into 11 output coefficients.

Background and Purpose It has recently been suggested that 5-HT3 receptor blockade enhances the efficacy of selective 5-HT (serotonin) reuptake inhibitor (SSRI) antidepressants and may reverse stress-induced deficits in rodents. Experimental Approach To further explore this hypothesis, we used mice lacking the 5-HT3 receptor (Htr3a KO) and their wild-type (WT) controls to assess their response in behavioural paradigms relevant to anxiety and depression. Mice were studied under basal, antidepressant treatments and chronic social defeat stress (CSDS) conditions. Key Results In basal conditions, Htr3a KO mice displayed anxiolytic- and antidepressant-like behaviours in the elevated plus maze, the social interaction and the forced swim tests (FST), but behaved as WT mice in response to acute citalopram in the FST. However, the effects of fluoxetine were blunted in Htr3a KO mice in these same tests. In an in vitro electrophysiological paradigm, a low-dose citalopram treatment triggered 5-HT1A receptor desensitization only in the dorsal raphe nucleus of Htr3a KO, although a high dose desensitized 5-HT1A autoreceptor function equally in Htr3a KO and WT mice, suggesting that citalopram may become effective at lower doses when 5-HT3 receptors are inactivated. In addition, Htr3a deletion blocked CSDS-induced modification in the cortical expression of two genes involved in oxidative stress, CaMKIIa and SOD1. Conclusions and Implications Taken together, these data show that Htr3a deletion promotes SSRI efficacy and prevents the occurrence of stress-induced deleterious effects, suggesting that the 5-HT3 receptor may represent an interesting target for the treatment of stress-related disorders.

Post-traumatic stress disorder (PTSD) is a trauma- and stress-related disorder with dysregulated fear responses and neurobiological impairments, notably at neurotrophic and inflammation levels. Understanding the mechanisms underlying this disease is crucial to develop PTSD models that meet behavioral and neurobiological validity criteria as well as innovative therapeutic approaches. Serotonin 2C receptors (5-HT2CR) are known for their important role in anxiety, and mice having only the fully edited VGV isoform of 5-HT2CR, which thereby overexpressed brain 5-HT2CR, are of special interest to study PTSD predisposition. Innate and conditioned fear-related behaviors were assessed in VGV and wild-type mice. mRNA expression of brain-derived neurotrophic factor (BDNF), tissue-plasminogen activator (tPA), and pro-inflammatory cytokines (IL-6, IL-1β, and calcineurin) were measured by qRT-PCR. The effect of acute and chronic paroxetine was evaluated on both behavior and gene expression. VGV mice displayed greater fear expression, extensive fear extinction deficits, and fear generalization. Paroxetine restored fear extinction in VGV mice when administered acutely and decreased innate fear and fear generalization when administered chronically. In parallel, Bdnf, tPA, and pro-inflammatory cytokines mRNA levels were dysregulated in VGV mice. Bdnf and tPA mRNA expression was decreased in the hippocampus but increased in the amygdala, and chronic paroxetine normalized Bdnf mRNA levels both in the amygdala and the hippocampus. Amygdalar calcineurin mRNA level in VGV mice was also normalized by chronic paroxetine. VGV-transgenic mice displayed behavioral and neurobiological features that could be accessory to the investigation of PTSD and its treatment. Furthermore, these data point out to the role of 5-HT2CR in neuroplasticity and neuroinflammation.

International audience; The charges in wide bandgap Gallium Nitride (GaN) High Electron Mobility Transistors (HEMT) can be identified by means of various methods such as electrical transient and pulsed measurements, or noise spectroscopy methods, usually performed at different temperatures to extract activation energies. These traps can be passivated or activated according to electrical or thermal conditions over the lifetime. Therefore, the distinction between harmful traps (with consequences on performances) and harmless traps (without impact on electrical behaviour) must be performed. In this paper, devices stressed by HTOL (High Temperature Operating Life) are characterized by time domain electrical techniques (transient and pulsed), and with low frequency noise (LFN) experimental tools. By performing characterizations on the gate and on the drain, it is also possible to identify the drain current sensitivity to charges located in specific regions of the transistor (command or channel zones). The proposed case study discriminates the traps in the GaN buffer and at the vicinity of the AlGaN/GaN interface. The HTOL stress impacts the traps at the interface border zone in the AlGaN layer. This causes a drift in the threshold voltage Vth, also with a hysteresis depending on direction of increasing or decreasing sweep of the gate voltage during the characterization. Also the Schottky diode leakage current profile at the transition voltage between forward and reverse biasing mode has been analysed versus temperature. The thermal sensitivity of the drift of the threshold voltage and of the transition voltage is attributed to the kinetics of ionization and neutralization of the donor traps with the applied gate voltage. This drift of Vth, and the action of many other traps or charges, cause the drain current to vary over time. These results are finally compared to those obtained by HTRB stress (High Temperature Reverse Bias), presenting similar degradation signatures over a longer stress period.

Growing evidence indicates that impairment of the stress response, in particular the negative feedback regulation mechanism exerted by the hypothalamo-pituitary-adrenal (HPA) axis, might be responsible for the hippocampal atrophy observed in depressed patients. Antidepressants, possibly through the activation of BDNF signaling, may enhance neuroplasticity and restore normal hippocampal functions. In this context, glucocorticoid receptor-impaired (GR-i) mice-a transgenic mouse model of reduced GR-induced negative feedback regulation of the HPA axis-were used to investigate the role of BDNF/TrkB signaling in the behavioral and neurochemical effects of the new generation antidepressant drug, agomelatine. GR-i mice exhibited marked alterations in depressive-like and anxiety-like behaviors, together with a decreased cell proliferation and altered levels of neuroplastic and epigenetic markers in the hippocampus. GR-i mice and their wild-type littermates were treated for 21 days with vehicle, agomelatine (50 mg/kg/day; i.p) or the TrkB inhibitor Ana-12 (0.5 mg/kg/day, i.p) alone, or in combination with agomelatine. Chronic treatment with agomelatine resulted in antidepressant like effects in GR-i mice and reversed the deficit in hippocampal cell proliferation and some of the alterations of mRNA plasticity markers in GR-i mice. Ana-12 blocked the effect of agomelatine on motor activity as well as its ability to restore a normal hippocampal cell proliferation and expression of neurotrophic factors. Altogether, our findings indicate that agomelatine requires TrkB signaling to reverse some of the molecular and behavioral alterations caused by HPA axis impairment.

International audience; The rapid development of III-V technologies for telecommunication and radar markets need the meeting of performances (power, frequency) criteria as well as reliability assessment. Nitride HEMT technologies are known to reveal a large variety of failure electrical signatures, and it is also largely accepted that multi-tools (multi physics) approaches is the only suitable way to understand the failure mechanisms and to improve the technologies. Experimental stress workbenches usually allow to track a given number of static/dynamic parameters, but specific characterization are only performed at initial and final steps on the devices. This paper proposes a new approach with S-parameters measurement performed during RF stresses without removing the devices under test (in a thermally controlled oven). Then intermediate knowledge of the electrical (small signal) behavior of the devices can be assessed, and crossed with large-signal and static time-dependent signatures.

It has recently been suggested that 5-HTTo further explore this hypothesis, we used mice lacking the 5-HTIn basal conditions, Htr3a KO mice displayed anxiolytic- and antidepressant-like behaviours in the elevated plus maze, the social interaction and the forced swim tests (FST), but behaved as WT mice in response to acute citalopram in the FST. However, the effects of fluoxetine were blunted in Htr3a KO mice in these same tests. In an in vitro electrophysiological paradigm, a low-dose citalopram treatment triggered 5-HTTaken together, these data show that Htr3a deletion promotes SSRI efficacy and prevents the occurrence of stress-induced deleterious effects, suggesting that the 5-HT

The photoluminescence properties of silicon nanocrystals in SiO2, prepared by low-pressure chemical vapour deposition and subsequent annealing have been studied. A comprehensive range of combinations of film compositions and annealing conditions were tested. The use of two-step annealing (a rapid annealing, followed by a conventional one) used instead of the common one-step conventional annealing, enhances emission. Annealing conditions are key to the photoluminescence and structural properties of the obtained film and have been investigated in detail. Film composition is also an important parameter, which allows tuning of the emission in a wide spectral range in the near infrared.

Rapid eye movement sleep can be elicited in the rat by microinjection of the cholinergic agonist carbachol into the oral pontine reticular nucleus. Intracerebroventricular administration, during the light period, of vasoactive intestinal peptide enhances rapid eye movement sleep in several species. Since this peptide is co-localized with acetylcholine in many neurons in the central nervous system, it was assumed that the oral pontine tegmentum could also be one target for vasoactive intestinal peptide to induce rapid eye movement sleep. This hypothesis was tested by recording the sleep-wakefulness cycle in freely-moving rats injected with vasoactive intestinal peptide or its fragments (1–12 and 10–28) directly into the oral pontine reticular nucleus. When administered into the posterior part of this nucleus, vasoactive intestinal peptide at 1 and 10 ng (in 0.1 μ l of saline), but not its fragments, induced a 2-fold enhancement of rapid eye movement sleep during 4 h, at the expense of wakefulness. At the dose of 10 ng, a significant increase in rapid eye movement sleep persisted for up to 8 h. Moreover, when the peptide was injected into the centre of the positive zone, rapid eye movement sleep was enhanced during three to eight consecutive days. These data provide the first evidence that rapid eye movement sleep can be elicited at both short- and long-term by a single intracerebral microinjection of vasoactive intestinal peptide. Peptidergic mechanisms, possibly in association with cholinergic mechanisms, within the caudal part of the oral pontine reticular nucleus may play a critical role in the long-term regulation of rapid eye movement sleep in rats.

International audience; Previous studies have shown that serotonin3 receptor activation in the nucleus tractus solitarius (NTS) increased mean arterial pressure (MAP) and inhibited the cardiac component of the baroreceptor reflex [9]. We have examined the effects of such stimulation upon spontaneous and evoked sympathetic nerve activity. Microinjection of serotonin (10 nmol) into the NTS of halothane-anaesthetized, paralyzed and artificially ventilated rats produced an increase in MAP and lumbar sympathetic nerve discharge which could be completely prevented by prior local microinjection of zacopride, a potent serotonin3 antagonist (200 pmol). In addition, 1-(m-chlorophenyl)-biguanide, a selective serotonin3 receptor agonist, mimicked the sympathoexcitatory effect of serotonin. Since the gain of the sympathetic component of the baroreflex was unaltered after intra-NTS microinjection of serotonin, it could be concluded that serotonin3 receptors activation in the NTS induces a sympathetic activation which is not mediated through an inhibition of the sympathetic baroreceptor reflex arc.

The 24-hour motor activity pattern was evaluated in 26 inpatients with major depression at treatment onset and after 4 weeks of antidepressant therapy. Clinical state, depression, and psychomotor retardation, as well as motor activity level and circadian rhythm, were simultaneously assessed. Treatment responders and nonresponders were also considered. Diurnal hypoactivity and reduced 24-hour rhythm amplitude were found at treatment onset. Activity level increased significantly on discharge. The rest-activity cycle for each depressed patient fit a cosine function of 24-hour periodicity. Data tended to show no phase shift but a large intragroup phase variability. Preliminary findings of a negative correlation between basic activity level and clinical improvement, and a trend toward responders having a lower activity level than nonresponders, suggest that activity could be used to predict therapeutic response.

The involvement of 5-HT1Breceptors in the regulation of vigilance states was assessed by investigating the spontaneous sleep–waking cycles and the effects of 5-HT receptor ligands on sleep in knock-out (5-HT1B−/−) mice that do not express this receptor type. Both 5-HT1B−/− and wild-type 129/Sv mice exhibited a clear-cut diurnal sleep–wakefulness rhythm, but knock-out animals were characterized by higher amounts of paradoxical sleep and lower amounts of slow-wave sleep during the light phase and by a lack of paradoxical sleep rebound after deprivation. In wild-type mice, the 5-HT1Bagonists CP 94253 (1–10 mg/kg, i.p.) and RU 24969 (0.25–2.0 mg/kg, i.p.) induced a dose-dependent reduction of paradoxical sleep during the 2–6 hr after injection, whereas the 5-HT1B/1Dantagonist GR 127935 (0.1–1.0 mg/kg, i.p.) enhanced paradoxical sleep. In addition, pretreatment with GR 127935, but not with the 5-HT1Aantagonist WAY 100635, prevented the effects of both 5-HT1Bagonists. In contrast, none of the 5-HT1Breceptor ligands, at the same doses as those used in wild-type mice, had any effect on sleep in 5-HT1B−/− mutants. Finally, the 5-HT1Aagonist 8-OH-DPAT (0.2–1.2 mg/kg, s.c.) induced in both strains a reduction in the amount of paradoxical sleep. Altogether, these data indicate that 5-HT1Breceptors participate in the regulation of paradoxical sleep in the mouse.

Our aim was to determine whether the cardiovascular neurones in the rostro-ventrolateral medulla (CV-RVLM neurones) were involved in the sympathoexcitation induced by stimulation of 5-HT3 receptors in the region of the nucleus tractus solitarii (NTS). Experiments were performed in pentobarbitone-anaesthetized rats, artificially ventilated and paralysed with pancuronium bromide. Using extracellular recordings, different types of RVLM neurones were characterized: cardiovascular (CV), ventilation-related and baroreflex-insensitive (unidentified) neurones. The CV-RVLM cells were further subdivided into three populations according to their axonal conduction velocities: A (1.2 ± 0.1 m s−1), B (2.5 ± 0.2 m s−1) and C (6.8 ± 1.1 m s−1). Only the CV-RVLM neurones of the A and B categories were partially inhibited (−30 %) by a hypotensive dose (2.5 μg kg−1 i.v.) of clonidine. Microinjections into the region of the commissural NTS of 1-(m-chlorophenyl)-biguanide (CPBG, 2 nmol), a selective 5-HT3 receptor agonist, elicited an increase in both lumbar sympathetic nerve discharge (SND) and arterial pressure. In addition, this treatment produced a marked excitation of CV-RVLM neurones of the A and B categories, without affecting those of the C type, as well as ventilation-related and unidentified RVLM cells. The activity of the CV neurones in the caudo-ventrolateral part of the medulla oblongata (CV-CVLM) was not modified by 5-HT3 receptor stimulation in the NTS. Prior intra-NTS microinjections of ondansetron (300 pmol, a selective 5-HT3 receptor antagonist) into the region of the commissural NTS prevented the excitation of A and B CV-RVLM neurones induced by CPBG. Intracarotid administration of saline saturated with CO2 (chemoreceptor activation) elicited both an increase in the SND and an excitation of the clonidine-insensitive CV-RVLM neurones of the C type, without affecting A and B neurones. In conclusion, the sympathoexcitation elicited following 5-HT3 receptor stimulation in the region of the commissural NTS of pentobarbitone-anaesthetized rats seems to result from the excitation of two different pools of clonidine-sensitive CV-RVLM neurones. These neurones are apparently not involved in the sympathetic component of the chemoreceptor reflex. The rostro-ventrolateral medulla (RVLM) and nucleus tractus solitarii (NTS) are critically involved in the reflex control of sympathetic activity (Guyenet, Filtz & Donaldson, 1987; Sun & Guyenet, 1987; Spyer, 1994). The RVLM contains neurones that receive a number of inputs both peripheral and central in origin that influence sympathetic nerve activity (Sun & Guyenet, 1987; Spyer, 1994). Previous reports have described two populations of cardiovascular (CV)-RVLM neurones that project to the thoracic spinal cord (Brown & Guyenet, 1985; Sun & Guyenet, 1985). The first population consists of clonidine-sensitive cells with slow-conducting axons. The second population corresponds to cells that do not respond to hypotensive doses of clonidine, and are characterized by a much higher conduction velocity (Sun & Guyenet, 1986). The NTS is the site of termination of afferent fibres arising from arterial baroreceptors (baroreflex), cardiopulmonary chemoreceptors (Bezold-Jarisch reflex) and carotid chemoreceptors (chemoreflex) (Palkovits & Zaborsky, 1977; Kalia & Mesulam, 1980; Jordan & Spyer, 1986). For baro- and Bezold-Jarisch reflexes, which seem to share the same integrating mechanisms and pathways in the brain (Verberne & Guyenet, 1992), second-order neurones project from the NTS to the caudal ventrolateral part of the medulla (CVLM) (Gordon 1987; Guyenet et al. 1987; Verberne & Guyenet, 1992). These neurones exert an excitatory action on the GABAergic CVLM neurones that project to the RVLM where they inhibit the CV-RVLM neurones of this pressor area (Brown & Guyenet, 1985; Sun & Guyenet, 1985; Jeske, Reis & Milner, 1995). Some of the CV-RVLM neurones additionally constitute an efferent link in the sympathetic component of the chemoreflex (Guyenet & Brown, 1986; Sun & Reis, 1995). Indeed, it has been demonstrated that some NTS chemosensitive neurones have axonal projections to the RVLM (Koshiya & Guyenet, 1996). Within the NTS, serotonin (5-hydroxytryptamine, 5-HT) seems to be involved in the reflex control of blood pressure. Studies in both anaesthetized and conscious rats have shown that 5-HT2 receptor stimulation in the NTS elicits the typical CV responses of baroreceptor activation (Merahi, Orer & Laguzzi, 1992a; Callera, Bonagamba, Sevoz, Laguzzi & Machado, 1997a). On the other hand, stimulation of NTS 5-HT3 receptors elicits a chemoreceptor-like increase in arterial pressure and lumbar sympathetic activity (Merahi, Orer, Laporte, Gozlan, Hamon & Laguzzi, 1992b; Callera, Sevoz, Laguzzi & Machado, 1997b). In experiments aimed at analysing the mechanism (s) responsible for this sympatho-excitatory effect, we observed that stimulation of 5-HT3 receptors in the NTS did not inhibit the sympathetic component of the baroreflex (Nosjean, Franc & Laguzzi, 1995). Accordingly, it can be inferred that 5-HT3 receptor-mediated sympathoexcitation is not the consequence of the disruption of tonic baroreceptor sympathoinhibitory messages. However, our finding is compatible with the idea that CV-RVLM neurones may be involved in the sympathoexcitatory effect of 5-HT3 receptor stimulation in the NTS. In other experiments, we also observed that prior microinjections of pressor (nanomolar) doses of 5-HT3 receptor agonists into the NTS did not increase the sympathetic chemoreflex response (Sevoz, Callera, Machado, Hamon & Laguzzi, 1997). However, this observation does not rule out the possibility that under some physiological conditions, 5-HT released in the NTS may excite the NTS-RVLM sympathetic chemoreflex pathway (Koshiya & Guyenet, 1996), and the CV-RVLM neurones involved in this reflex. Indeed, as previously observed with the pressor chemoreflex response (Sun & Reis, 1995), we recently found that the microinjection of kynurenic acid, a glutamate receptor antagonist, into the RVLM blocked the pressor effects elicited by 5-HT3 receptor stimulation in this area (Sevoz, Hamon & Laguzzi, 1996b). In order to elucidate the possible role of CV-RVLM neurones in the sympathetic response to 5-HT3 receptor stimulation in the NTS, we have analysed the effects of intra-NTS microinjections of a potent and selective 5-HT3 receptor agonist, 1-(m-chlorophenyl)-biguanide (CPBG), as well as the effects of chemoreflex activation, on the activity of the different categories of RVLM neurones. In addition, the possible effects of intra-NTS administration of CPBG on the CV-CVLM neurones were also investigated.

Anxiolytic drugs, such as the benzodiazepines and the azapirones (ipsapirone, gepirone, buspirone), are well known to affect states of vigilance and to decrease the firing rate of serotoninergic neurones within the dorsal raphe nucleus in rats. In order to examine whether the newly developed 5-HT3 antagonists with potential anxiolytic properties act through similar mechanisms, the effects of several of such antagonists: MDL 72222, ICS 205-930, ondansetron and/or zacopride on both sleep-wakefulness and the discharge of serotoninergic neurones within the dorsal raphe nucleus were investigated in rats. When tested in a wide range of doses (0.05-10 mg/kg, i.p.), none of these drugs significantly affected the states of vigilance, except ondansetron, at 0.1 mg/kg, which increased paradoxical sleep for the first 2 hr after administration and MDL 72222, at 10 mg/kg, which reduced both paradoxical and slow wave sleep and increased wakefulness for the same initial period after treatment. In vivo, in chloral hydrate anaesthetized rats, as well as in vitro, in slices of brain stem, none of the 5-HT3 antagonists tested affected the firing rate of serotoninergic neurones. Similarly, no change in the electrical activity of serotoninergic neurones could be evoked in vitro by superfusion of the tissue with the 5-HT3 agonists, phenylbiguanide (10 microM) and 2-methyl-5-HT (1 microM). At a larger concentration (10 microM), the latter compound reduced the neuronal discharge probably through the stimulation of somatodendritic 5-HT1A autoreceptors since this effect, as that of ipsapirone, could be prevented by 10 microM l-propranolol. Comparison of these data with those obtained with benzodiazepines and 5-HT1A agonists of the azapirone series, supports the concept that different mechanisms are responsible for the anxiolytic-like properties of 5-HT3 agonists, compared to those of other anxiolytic drugs.

The present study investigated the effects of two modalities of parenteral nutrition (continuous nutrition over the 24-hour period vs. cyclic nutrition, i.e., administered only during the night) on O2 consumption during sleep in children affected by severe gastrointestinal diseases. In both feeding modalities O2 consumption was always highest in REM sleep, intermediate in stage 2 and lowest in SWS. The trends during the night of O2 consumption (an increase from the second to the third part of the night) for different sleep stages were comparable in both feeding modalities. These results suggest that O2 consumption is not affected by the feeding modalities investigated, but is dependent on both sleep stages and time of night.

The aim of this study is to describe the time course of night sleep in the first year of life. Forty-eight infants aged between 1 and 54 weeks were polygraphically recorded for 1 night. The central occipital EEG derivation was processed with a lab computer in order to obtain every 30 sec an EEG parameter value. The parameter is based on the joint frequency-amplitude distribution of the EEG and displays fluctuations between 2 extreme levels, high voltage low frequency (HVLF) and low voltage high frequency (LVHF). The range of the fluctuations between HVLF and LVHF increases from the period of 1–6 weeks to the period of 7–14 weeks. A further increase of the parameter range occurs after 24 weeks, which remains restricted to the first half of the night. The recurrence time of LVHF and HVLF episodes (possibly corresponding to quiet sleep paradoxical sleep cycles) is about 56 min and does not change with age in the first year of life.